Henriksen, K.L., Rasmussen, B.B., Lykkesfeldt, A.E., Møller, S., Ejlertsen, B. and Mouridsen, H.T. (2007) Semi-Quantitative Scoring of Potentially Predictive Markers for Endocrine Treatment of Breast Cancer: A Comparison between Whole Sections and Tissue Microarrays. Journal of Clinical Pathology, 60, 397-404.
https://dx.doi.org/10.1136/jcp.2005.034447

has been cited by the following article:

• TITLE: The Application of Quantum Dots Double-Labeling Immunofluorescence Technology in Detection of PR and CD146 in Paraffin-Embedded Tissue Sections of Endometrioid Adenocarcinoma

  AUTHORS: Jianping Zheng, Qing Huang, Lei Zhang, Yong Chen, Jinpeng Jiang, Cunjian Yi

  KEYWORDS: Endometrioid Adenocarcinoma, PR, CD146, QDs Double-Labeling Immunofluorescence

  JOURNAL NAME: Yangtze Medicine, Vol.1 No.1, March 30, 2017

  ABSTRACT: Objective: The aim was to detect the expression of PR and CD146 in paraf-fin-embedded tissue sections of endometrioid adenocarcinoma by using QDs double-labeling immunofluorescence, and evaluate the applied value of QDs double-labeling immunofluorescence in endometrioid adenocarcinoma. Methods: To detect the expression of PR and CD146 on 140 cases of paraffin-embedded tissue sections of endometrioid adenocarcinoma by using QDS double-labeling immunofluorescence. Results: The co-expression of PR and CD146 in the endometrioid adenocarcinoma can be detected by QDs double-labeling immunofluorescence, and there was no correlation between them (P > 0.05). Conclusion: QDs double-labeling immunofluorescence can detect the localization and co-expression of PR and CD146 in the endometrioid adenocarcinoma.